CANDRIAM S.C.A. – AstraZeneca PLC Transaction History
CANDRIAM S.C.A. portfolio value:
$33.45M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-17.00%
quarter
AstraZeneca PLC 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.29% | -34.10K shares | -9.10M | $54.84 | 610.02K |
| Q2 2022 | share | Decrease | -26.62% | -233.72K shares | -15.67M | $66.07 | 644.13K |
| Q1 2022 | share | Decrease | -17.28% | -183.35K shares | -3.58M | $66.34 | 877.86K |
| Q4 2021 | share | Increase | +3.19% | 32.77K shares | 50K | $58.47 | 1.06M |
| Q3 2021 | share | Increase | +299.57% | 771.04K shares | 46.34M | $60.06 | 1.02M |
| Q2 2021 | share | Increase | +57.34% | 93.80K shares | 7.56M | $59.44 | 257.38K |
| Q1 2021 | share | Increase | +0.07% | 116 shares | -316K | $49.34 | 163.58K |
| Q4 2020 | share | Increase | +37.25% | 44.36K shares | 1.64M | $48.68 | 163.46K |
| Q3 2020 | share | Increase | +117.80% | 64.41K shares | 3.63M | $53.37 | 119.10K |
| Q2 2020 | share | Decrease | -45.36% | -45.39K shares | -1.98M | $51.1 | 54.68K |
| Q1 2020 | share | Increase | +0.06% | 63 shares | -109K | $43.15 | 100.07K |
| Q4 2019 | share | Increase | 0.00% | 100.01K shares | 4.98M | $47.17 | 100.01K |
| Q1 2018 | share | Decrease | -100.00% | -21.2K shares | -736K | $31.66 | 0 |
| Q4 2017 | share | Decrease | -39.21% | -13.67K shares | -446K | $30.56 | 21.2K |
| Q3 2017 | share | Decrease | -2.25% | -804 shares | -34K | $29.84 | 34.87K |
| Q2 2017 | share | 0.00% | 0 shares | 105K | $29.58 | 35.68K | |
| Q1 2017 | share | 0.00% | 0 shares | 136K | $27.02 | 35.68K | |
| Q4 2016 | share | 0.00% | 0 shares | -197K | $22.97 | 35.68K | |
| Q3 2016 | share | Decrease | -10.80% | -4.32K shares | -36K | $27.63 | 35.68K |
| Q2 2016 | share | Increase | 0.00% | 40K shares | 1.20M | $25.05 | 40K |